Glow Blend 70mg

Glow Blend Research and Composition

Glow blend is a multi-peptide research formulation combining three extensively studied compounds in a single lyophilised vial. Each 70mg vial contains BPC-157 (10mg), TB-500 (10mg) and GHK-Cu (50mg) in a 5:1:1 ratio designed for multi-pathway research applications. This ratio ensures each component reaches its effective analytical threshold simultaneously, allowing researchers to study cellular repair, tissue regeneration, collagen signalling and inflammation pathways within a single integrated protocol. According to research protocol guides, the 5:1:1 ratio reflects the different dosing requirements of each component, with GHK-Cu requiring higher absolute concentrations to achieve systemic effects in preclinical models while BPC-157 and TB-500 demonstrate activity at lower concentrations.citeweb_search:11#2

BPC-157 is a 15-amino-acid peptide derived from gastric juice, studied for cellular protection, angiogenesis and gut-brain axis modulation. TB-500 is a synthetic fragment of thymosin beta-4, researched for cell migration, actin regulation and tissue repair. GHK-Cu is a naturally occurring copper tripeptide that modulates gene expression across approximately 4,000 human genes, with documented effects on collagen synthesis, elastin production and wound healing. Together these compounds create a synergistic research cascade where GHK-Cu provides the copper cofactor and gene expression modulation, BPC-157 drives tissue protection and angiogenesis, and TB-500 enhances cell migration and structural protein function. This product is sold strictly for in vitro and laboratory research use only. It is not approved by the TGA or FDA for human consumption, therapeutic use, or diagnosis.

Glow Blend Dosage and Reconstitution

Glow Blend 70mg Dosage for Research Protocols

For laboratory research, the standard glow blend 70mg dosage protocol uses 2.33mg of total blend daily, which breaks down to approximately 1.7mg GHK-Cu, 330mcg TB-500 and 330mcg BPC-157. This protocol is achieved by reconstituting the 70mg vial with 3.0mL of bacteriostatic water to create a concentration of 23.33mg per mL, then drawing 0.10mL (10 units on an insulin syringe) per daily administration. Researchers investigating glow blend dosage should note that this standard protocol provides approximately 30 days of doses from a single 70mg vial. Conservative protocols for method development use 1.165mg daily (5 units), while intensive protocols for accelerated injury recovery models may use 4.66mg daily split across two administrations. All dosing parameters are for research reference only.

Reconstitution Guide

Remove the vial from freezer storage and allow it to equilibrate to room temperature for 15 to 20 minutes. Draw 3.0mL of bacteriostatic water into a sterile syringe and inject slowly down the inner vial wall to minimise foaming. Do not shoot water directly at the lyophilised powder. Allow the solution to dissolve naturally for 5 to 15 minutes. Gently roll the vial between your palms if needed, but never shake vigorously. The solution should become clear. Label with the reconstitution date and concentration. Store at 2 to 8 degrees C protected from light. Use within 4 weeks. Do not freeze reconstituted solution.

How Glow Blend Compares to Other Research Compounds

Glow Blend vs Individual Peptides

Researchers often ask whether to purchase glow blend or buy BPC-157, TB-500 and GHK-Cu separately. The glow blend offers a multi-pathway research approach in a single vial, reducing reconstitution variables and ensuring consistent ratio administration across assay replicates. Individual peptides allow custom dosing ratios and independent batch tracking, which may be preferable for studies requiring isolated mechanism validation. For integrated regeneration models studying collagen signalling, inflammation response and tissue repair simultaneously, glow blend provides a more streamlined research tool. For targeted single-pathway studies, individual BPC-157, TB-500 or GHK-Cu may be more appropriate.

Glow Blend vs BPC-157 TB-500 GHK-Cu 30mg Glow Blend

Some suppliers offer a bpc 157 tb 500 ghk cu 30mg glow blend variant containing smaller total quantities of each component. Our 70mg glow blend provides proportionally higher analytical material per vial, allowing extended protocol durations or higher-concentration assay work without requiring multiple vials. The 70mg format is particularly valuable for research institutions running multi-week studies or requiring replicate consistency across larger sample sizes. Both formats maintain the 5:1:1 ratio, but the 70mg vial offers greater experimental flexibility and cost efficiency per milligram for extended research protocols.

Glow Blend vs Wolverine Stack

The wolverine stack typically refers to BPC-157 plus TB-500 without GHK-Cu. Glow blend adds the copper tripeptide to create a three-component system addressing tissue repair, cell migration and collagen gene expression simultaneously. For pure musculoskeletal injury recovery research, the wolverine stack may provide sufficient analytical focus. For studies incorporating skin regeneration, hair biology, oxidative stress or broader collagen remodelling, glow blend offers a more comprehensive research profile due to the inclusion of GHK-Cu.

Glow Blend vs 5 Amino 1mq

5 amino 1mq is a small molecule NNMT inhibitor studied for metabolic regulation through NAD+ and SIRT1 pathways. Glow blend is a peptide-based tissue repair and regeneration stack. 5 amino 1mq is typically investigated for body composition and adipose tissue metabolism, while glow blend is investigated for cellular repair, collagen synthesis and wound healing. These compounds address entirely different research categories and are not interchangeable.

Glow Blend vs AOD-9604

AOD-9604 is a modified HGH fragment studied for direct lipolysis via beta-3 adrenergic receptor pathways. Glow blend is a tissue repair and regeneration peptide stack with no lipolytic mechanism. AOD-9604 is positioned for fat metabolism research, while glow blend is positioned for cellular repair, skin biology and musculoskeletal recovery. They are distinct research tools with different primary applications.

Glow Blend vs MOTS-c

MOTS-c is a mitochondrial-derived peptide that activates AMPK and regulates cellular energy homeostasis. Glow blend is a tissue repair stack targeting collagen synthesis, angiogenesis and cell migration. MOTS-c is studied for metabolic adaptation and exercise mimetics, while glow blend is studied for structural repair and regenerative biology. These are complementary but non-overlapping research categories.

Product Specifications

Purity and Analysis

• Total content: 70mg lyophilised powder
• Composition: BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg
• Ratio: 5:1:1 (GHK-Cu:TB-500:BPC-157)
• Purity: Greater than or equal to 98% by HPLC per component
• Appearance: White to off-white lyophilised powder
• Source: Synthetic, manufactured via solid-phase peptide synthesis

Each batch is independently tested. Request the Certificate of Analysis (COA) for your specific batch number to verify purity, mass spec, and chromatography data for all three components.

Storage and Handling

• Lyophilised storage: -20 degrees C, protected from light and moisture
• Shelf life (unreconstituted): 24 months when stored correctly
• Handling: Use sterile technique. Avoid repeated freeze-thaw cycles

Shipping and Returns

We ship glow blend from our Australian facility via express domestic courier. Orders placed before 2:00 PM AEST dispatch the same business day. All peptide orders are packaged in insulated, discreet packaging with cold-chain protection where required.

• Minimum order: $200 AUD
• Free shipping: Orders over $200 AUD
• Flat rate: $15 AUD for orders under $200
• Delivery time: 1 to 5 business days Australia-wide
• Returns: Unopened vials may be returned within 30 days of delivery for store credit or replacement. We do not accept returns on reconstituted or opened products due to stability concerns. Read the full returns policy.

Frequently Asked Questions

What is glow blend peptide
Glow blend peptide is a research-grade combination of BPC-157, TB-500 and GHK-Cu in a 5:1:1 ratio. It is designed for laboratory studies exploring cellular repair, tissue regeneration, collagen signalling and inflammation pathways.

Glow blend peptides what is it
Glow blend peptides refers to the three-component stack contained in the vial: BPC-157 (body protection compound), TB-500 (thymosin beta-4 fragment) and GHK-Cu (copper tripeptide). Each contributes distinct mechanisms to create a synergistic research cascade.

Glow blend dosage for research
The standard research protocol uses 2.33mg daily from a 70mg vial reconstituted with 3.0mL bacteriostatic water. This provides approximately 30 days of administration. Conservative protocols use 1.165mg daily. All dosing is for laboratory research only.

Glow blend 70mg dosage vs smaller vials
The 70mg vial provides greater experimental flexibility and cost efficiency per milligram compared to 30mg or 42mg variants. It supports extended protocols or higher replicate counts without requiring multiple vials.

Can I buy glow blend as individual peptides
Yes. Pure Peptide Factory stocks BPC-157, TB-500 and GHK-Cu as individual research products. The glow blend is designed for researchers who want the pre-formulated 5:1:1 ratio in a single vial.

Is glow blend approved for human use
No. Glow blend is strictly for research and laboratory use. It is not approved by the TGA for human consumption, therapeutic application, or clinical use.

Do you ship outside Australia
Currently, we only ship to Australian addresses. We do not export peptides due to varying international customs regulations.

How do I verify the purity of my batch
Every batch ships with a unique batch number. Enter this number on our COA lookup page to download the HPLC and mass spec report for your specific vial.